(Q34575450)

3 August 2017

title

Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents (English)

1 reference

3 August 2017

John F Cryan

9

0 references

author name string

Sharon Rosenzweig-Lipson

1

1 reference

3 August 2017

Annmarie Sabb

2

1 reference

3 August 2017

Gary Stack

3

1 reference

3 August 2017

Paul Mitchell

4

1 reference

3 August 2017

Irwin Lucki

5

1 reference

3 August 2017

Jessica E Malberg

6

1 reference

3 August 2017

Steve Grauer

7

1 reference

3 August 2017

Julie Brennan

8

1 reference

3 August 2017

Stacey J Sukoff Rizzo

10

1 reference

3 August 2017

John Dunlop

11

1 reference

3 August 2017

James E Barrett

12

1 reference

3 August 2017

Karen L Marquis

13

1 reference

3 August 2017

publication date

13 February 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

192

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

159-170

1 reference

5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential

3 August 2017

cites work

1 reference

12 December 2020

Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin.

1 reference

12 December 2020

Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder

1 reference

12 December 2020

Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected?

1 reference

12 December 2020

Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors.

1 reference

12 December 2020

5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats

1 reference

12 December 2020

Synthesis and 5-hydroxytryptamine (5-HT) activity of 2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5-(6H)ones and 2,3,4,4a,5,6-hexahydro-1H-pyrazino[1,2-a]quinoxalines

1 reference

12 December 2020

Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioural responses to mCPP.

1 reference

12 December 2020

Acute and chronic antidepressant drug treatments induce opposite effects in the social behaviour of rats.

1 reference

12 December 2020

Differentiating antidepressants of the future: efficacy and safety

1 reference

12 December 2020

Compulsive behavior in the 5-HT2C receptor knockout mouse

1 reference

12 December 2020

Animal models of depressive illness: the importance of chronic drug treatment

1 reference

12 December 2020

Antidepressants preferentially enhance habituation to novelty in the olfactory bulbectomized rat.

1 reference

12 December 2020

Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated

1 reference

12 December 2020

Antiobesity effect of YM348, a novel 5-HT2C receptor agonist, in Zucker rats

1 reference

12 December 2020

Involvement of 5-HT(2C) receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice

1 reference

12 December 2020

Depression: a new animal model sensitive to antidepressant treatments

1 reference

12 December 2020

Effects of chronic fluoxetine treatment in the presence and absence of (+/-)pindolol: a microdialysis study

1 reference

12 December 2020

Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia.

1 reference

12 December 2020

Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist

1 reference

12 December 2020

A novel approach for predicting antidepressant-induced sexual dysfunction in rats

1 reference

12 December 2020

WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activity

1 reference

12 December 2020

Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade

1 reference

12 December 2020

Novel agonists of 5HT2C receptors. Synthesis and biological evaluation of substituted 2-(indol-1-yl)-1-methylethylamines and 2-(indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved therapeutics for obsessive compulsive disorder

1 reference

12 December 2020

WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity

1 reference

12 December 2020

Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat.

1 reference

12 December 2020

Effects of repeated mild stress and two antidepressant treatments on the behavioral response to 5HT1C receptor activation in rats.

1 reference

12 December 2020

Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.

1 reference

12 December 2020

Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

1 reference

12 December 2020

Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study

1 reference

12 December 2020

Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats.

1 reference

12 December 2020

Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503.

1 reference

12 December 2020

Acceleration of onset of action in schedule-induced polydipsia: combinations of SSRI and 5-HT1A and 5-HT1B receptor antagonists

1 reference

12 December 2020

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist

1 reference

12 December 2020

Cycloalkyl[b][1,4]benzodiazepinoindoles are agonists at the human 5-HT2C receptor

1 reference

12 December 2020

The olfactory bulbectomized rat as a model of depression: an update

1 reference

12 December 2020

10.1007/S00213-007-0710-6

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1016704712

0 references

1 reference